Literature DB >> 14613629

The detection of antibodies against Schistosoma mansoni soluble egg antigens (SEA) and CEF6 in ELISA, before and after chemotherapy.

M J Doenhoff1, J G Wheeler, K Tricker, J V Hamilton, R F Sturrock, A E Butterworth, J H Ouma, G G Mbugua, C Kariuki, D Koech.   

Abstract

Circulating IgG antibody reactivity and excreted egg counts were investigated in 489 Kenyans given chemotherapy for schistosomiasis mansoni. Antibody reactivity was measured in ELISA, using either unfractionated aqueous soluble constituents of Schistosoma mansoni eggs (SEA) or CEF6 (a soluble fraction of S. mansoni eggs containing two cationic antigens) as the antigen source. Antibody reactivity for each antigen source was strongly associated with egg counts, both pre- and post-treatment. Approximately 6 months after chemotherapy, egg counts were zero in 84% of the subjects. The mean optical densities (OD) measured in the post-treatment ELISA were 60% (CEF6) or 45% (SEA) lower than the pre-treatment values, the reduction in the OD with CEF6 as antigen source being significantly greater than that observed with SEA (P <0.001). The usefulness of an assay for antibody reactivity in monitoring the effects of the treatment of schistosomiasis is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14613629     DOI: 10.1179/000349803225002354

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  6 in total

1.  Impact of short-time urine freezing on the sensitivity of an established Schistosoma real-time PCR assay.

Authors:  Hilaire M Kenguele; Ayola A Adegnika; Anne-Marie Nkoma; Ulysse Ateba-Ngoa; Mirabeau Mbong; Jeannot Zinsou; Bertrand Lell; Jaco J Verweij
Journal:  Am J Trop Med Hyg       Date:  2014-04-07       Impact factor: 2.345

2.  Helminths: an unrecognised disease burden prevalent among migrants in the gastroenterology clinic.

Authors:  P J Smith; B Theis; S McCartney; M Brown
Journal:  Frontline Gastroenterol       Date:  2010-12-23

3.  Comparison of Recombinant Proteins from Schistosoma japonicum for Schistosomiasis Diagnosis.

Authors:  Ya-mei Jin; Ke Lu; Wei-Fang Zhou; Zhi-Qiang Fu; Jin-Ming Liu; Yao-Jun Shi; Hao Li; Jiao-Jiao Lin
Journal:  Clin Vaccine Immunol       Date:  2010-01-06

4.  Comparison of Schistosoma mansoni soluble cercarial antigens and soluble egg antigens for serodiagnosing schistosome infections.

Authors:  Huw Smith; Mike Doenhoff; Cara Aitken; Wendi Bailey; Minjun Ji; Emily Dawson; Henk Gilis; Grant Spence; Claire Alexander; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13

5.  Selecting targets for the diagnosis of Schistosoma mansoni infection: An integrative approach using multi-omic and immunoinformatics data.

Authors:  Gardenia B F Carvalho; Daniela M Resende; Liliane M V Siqueira; Marcelo D Lopes; Débora O Lopes; Paulo Marcos Z Coelho; Andréa Teixeira-Carvalho; Jeronimo C Ruiz; Cristina T Fonseca
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

6.  Schistosoma mansoni treatment reduces HIV entry into cervical CD4+ T cells and induces IFN-I pathways.

Authors:  Sergey Yegorov; Vineet Joag; Ronald M Galiwango; Sara V Good; Juliet Mpendo; Egbert Tannich; Andrea K Boggild; Noah Kiwanuka; Bernard S Bagaya; Rupert Kaul
Journal:  Nat Commun       Date:  2019-05-24       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.